Korean J Psychopharmacol.  2003 Dec;14(4):377-386.

Dopamine Transporter Density of the Basal Ganglia as a Predictor of Methylphenidate Response in Children with Attention Deficit Hyperactivity Disorder-A [123I]IPT SPECT Study

Affiliations
  • 1Department of Psychiatry, College of Medicine, Yonsei University, Seoul, Korea.
  • 2Division of Nuclear Medicine, Department of Radiology, College of Medicine, Yonsei University, Seoul, Korea.
  • 3Department of Psychiatry, College of Medicine, Kwandong University, Gangneung, Korea.

Abstract


OBJECTIVE
Dopamine transporter is a key regulator of dopamine neurotransmission and is also the primary target of methylphenidate. This study tested the hypothesis that dopamine transporter (DAT) density in basal ganglia is a predictor of favorable methylphenidate (MP) treatment response. METHODS: 15 drug-naive boys with ADHD were included in this study (8 children: treatment responder, 7 children: treatment non responder). They were assessed with psychiatric interview, KEDI-WISC, K-ARS, ADS and CBCL. After then, they were performed [123 I]IPT SPECT. They were evaluated about treatment response after treatment with methylphenidate during 8 weeks. SPECT data reconstructed for the assessment of specific/nonspecific DAT binding ratio of the basal ganglia were compared between treatment responders and nonresponders. RESULTS: There were not significant differences in dopamine transporter density in basal ganglia between the two groups. CONCLUSION: This finding suggests that dopamine transporter density does not mediate the MP treatment response in a direct way.

Keyword

DAT; Methylphenidate; Treatment response; SPECT

MeSH Terms

Basal Ganglia*
Child*
Dopamine Plasma Membrane Transport Proteins*
Dopamine*
Humans
Methylphenidate*
Synaptic Transmission
Tomography, Emission-Computed, Single-Photon*
Dopamine
Dopamine Plasma Membrane Transport Proteins
Methylphenidate
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr